IGC Pharma (IGC) Other Gross PP&E Adjustments (2016 - 2025)
IGC Pharma (IGC) has disclosed Other Gross PP&E Adjustments for 14 consecutive years, with $3.9 million as the latest value for Q3 2025.
- On a quarterly basis, Other Gross PP&E Adjustments fell 34.34% to $3.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.9 million, a 34.34% decrease, with the full-year FY2025 number at $5.8 million, down 2.09% from a year prior.
- Other Gross PP&E Adjustments was $3.9 million for Q3 2025 at IGC Pharma, down from $5.9 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $13.3 million in Q4 2021 to a low of $3.9 million in Q3 2025.
- A 5-year average of $9.1 million and a median of $9.8 million in 2023 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: increased 13.35% in 2021, then crashed 40.24% in 2024.
- IGC Pharma's Other Gross PP&E Adjustments stood at $13.3 million in 2021, then fell by 26.98% to $9.7 million in 2022, then dropped by 24.35% to $7.4 million in 2023, then decreased by 21.01% to $5.8 million in 2024, then crashed by 33.45% to $3.9 million in 2025.
- Per Business Quant, the three most recent readings for IGC's Other Gross PP&E Adjustments are $3.9 million (Q3 2025), $5.9 million (Q2 2025), and $5.8 million (Q1 2025).